Abstract
This study was conducted to investigate the in vitro anticancer reinforcing effects of neferine (Nef) on dehydroepiandrosterone (DHEA) and the mechanism was also determined during the investigation. By the growth effects of Nef and DHEA on MCF-7 human breast cancer cells, 8 mg/mL Nef was a non-virulent concentration in MCF-7 cells, and this concentration was used for further experiment. In 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide assay, 30 mg/mL DHEA showed 49.4 % growth inhibitory effect in MCF-7 cells, whereas Nef (8 mg/mL) + DHEA (30 mg/mL) treatment had the higher effect at 67.8 %. The flow cytometry analysis results showed that 15 and 30 mg/mL DHEA-treated MCF-7 cells had 12.2 and 21.6 % apoptotic cells, respectively, Nef + DHEA could raise the apoptotic cells to 36.7 %. Reverse transcription-polymerase chain reaction assay shows remarkable results according to which DHEA could significantly increase caspase-3, caspase-8, caspase-9, Bax, p53, p21, E2F1, Fas, FasL mRNA expressions and decrease Bcl-2, Bcl-xL, HIAP-1, HIAP-2, survivin expressions as compared to the untreated control cancer cells. Moreover, these effects depend on the concentration of DHEA, and Nef which could further strengthen these effects. From these results, low concentration of Nef could not influence the growth of MCF-7 cells, but using its sensitization effect, Nef raised the in vitro effects of DHEA. Nef could be got easily. With these results we can accomplish that Nef + DHEA might be used as the new anticancer materials combination.
Similar content being viewed by others
References
Adams JM, Cory S (2007) Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 19:488–496
Asselin E, Mills GB, Tsang BK (2001) XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 61:1862–1868
Atari-Hajipirloo S, Nikanfar S, Heydari A, Noori F, Kheradmand F (2016) The effect of celecoxib and its combination with imatinib on human HT-29 colorectal cancer cells: Involvement of COX-2, Caspase-3, VEGF and NF-κB genes expression. Cell Mol Biol (Noisy-le-grand) 62: 68–74
Bajwa N, Liao CZ, Nikolovska-Coleska Z (2012) Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review. Expert Opin Ther Pat 22:37–55
Bao J, Zhou JN, Tang XQ, Cao JG (2003) Enhancement of cytotoxicity of Adramycin by neferine in Saos-2 cells and its mechanism. Chin Pharm Bull 19:80–82
Cheung CH, Huang CC, Tsai FY, Lee JY, Cheng SM, Chang YC, Huang YC, Chen SH, Chang JY (2013) Survivin—biology and potential as a therapeutic target in oncology. Onco Targets Ther 6:1453–1462
Dang DK, Shin EJ, Nam YS, Ryoo SW, Jeong JH, Jang CG, Nabeshima T, Hong JS, Kim HC (2016) J Neuroinflammation 13:12
Fan ZH (2010) The comparison between normal cells and cancer cells in the body. Front Sci Technol 2010:132
Furukawa Y, Nishimura N, Furukawa Y, Satoh M, Endo H, Iwase S, Yamada H, Matsuda M, Kano Y, Nakamura M (2002) Apaf-1 is a mediator of E2F-1-induced apoptosis. J Biol Chem 277:39760–39768
Gogada R, Yadav N, Liu J, Tang S, Zhang D, Schneider A, Seshadri A, Sun L, Aldaz CM, Tang DG, Chandra D (2013) Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer. J Biol Chem 288:368–381
Han S, Woo JK, Jung Y, Jeong D, Kang M, Yoo YJ, Lee H, Oh SH, Ryu JH, Kim WY (2016) Evodiamine selectively targets cancer stem-like cells through the p53-p21-Rb pathway. Biochem Biophys Res Commun 469:1153–1158
Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N (2014) Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2014:150845
Hu WS, Guo LJ, Feng XL, Jiang MX (1990) Hypotensive effects of neferine. Chin J Pharm Toxicol 4:107–110
Hu Y, Benedict MA, Ding L, Núñez G (1999) Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J 18:3586–3595
Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin WG Jr (2000) Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407:645–648
Jeong JW, Lee WS, Go SI, Nagappan A, Baek JY, Lee JD, Lee SJ, Park C, Kim GY, Kim HJ, Kim GS, Kwon TK, Ryu CH, Shin SC, Choi YH (2015) Pachymic acid induces apoptosis of EJ bladder cancer cells by DR5 up-regulation, ROS generation, modulation of Bcl-2 and IAP family members. Phytother Res 29:1516–1524
Jia JF, Ao MZ, Hu BR, Li YJ, Guo MD, Mo CG (1994) The effects of neferine on lipid peroxides and active oxygen free radical. Acta Univ Med Tangji 23:62–66
Lawen A (2003) Apoptosis-an introduction. BioEssays 25:888–896
Liu XX, Arnold JT, Blackman MR (2010) Dehydroepiandrosterone administration or Gαq overexpression induces β-catenin/T-cell factor signaling and growth via increasing association of estrogen receptor-β/dishevelled2 in androgen-independent prostate cancer cells. Endocrinology 151:1428–1440
Lo Russo G, Proto C, Garassino MC (2016) Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake? Transl Lung Cancer Res 5:110–114
Mannic T, Viguie J, Rossier MF (2015) In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system. Int J Endocrinol Metab 13:e24660
Matsumura I, Tanaka H, Kanakura Y (2003) E2F1 and c-Myc in cell growth and death. Cell Cycle 2:333–338
McStay GP, Green DR (2014) Preparation of cytosolic extracts and activation of caspases by cytochrome c. Cold Spring Harb Protoc 2014:778–782
Nakajima-Shimada J, Zou C, Takagi M, Umeda M, Nara T, Aoki T (2000) Inhibition of Fas-mediated apoptosis by Trypanosoma cruzi infection. Biochim Biophys Acta 1475:175–183
Nam C, Doi K, Nakayama H (2010) Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway. Histol Histopathol 25:485–493
Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF (2002) E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol 22:5308–5318
Samaras N, Samaras N, Frangos E, Forster A, Philippe J (2013) A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res 16:285–294
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675–1687
Su ZY, Yang ZZ, Xu YQ, Chen YB, Yu Q (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:48
Sun Z, Wan ZY, Guo YS, Wang HQ, Luo ZJ (2013) FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells. Int J Clin Exp Pathol 6:2376–2385
Tang XQ, Cao JG (2001) Enhancement of cytotoxicity of anticancer drugs in vitro by neferine in MCF- 7 cells. Chin J Mod App Pharm 18:345–347
Teng Y, Litchfield LM, Ivanova MM, Prough RA, Clark BJ, Klinge CM (2014) Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor. Mol Cell Endocrinol 392:23–36
Um HD (2015) Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species. Oncotarget 7:5193–5203
Wang Y, Tjandra N (2013) Structural insights of tBid, the caspase-8-activated Bid, and its BH3 domain. J Biol Chem 288:35840–35851
Wang C, Chen YF, Quan XQ, Wang H, Zhang R, Xiao JH, Wang JL, Zhang CT, Xiang JZ, Tang Q (2015a) Effects of neferine on Kv4.3 channels expressed in HEK293 cells and ex vivo electrophysiology of rabbit hearts. Acta Pharmacol Sin 36:1451–1461
Wang ES, Reyes NA, Melton C, Huskey NE, Momcilovic O, Goga A, Blelloch R, Oakes SA (2015b) Fas-activated mitochondrial apoptosis culls stalled embryonic stem cells to promote differentiation. Curr Biol 25:3110–3118
Webb SJ, Geoghegan TE, Prough RA (2006) The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38:89–116
Xia GJ, Liu YF, Lu FH (1986) Effects of methyl-liensinine on experimental arrhythmias. J Tongji Med Univ 1986:200–203
Yang S, Fu ZD, Han Y (2001) Studies on the anti-tumorpromotion activities of dehydroepiandrosterone and its mechanism of action. Acta Pharm Sin 36:576–580
Yu Y, Sun S, Wang S, Zhang Q, Li M, Lan F, Li S, Liu C (2016) Liensinine- and neferine-induced cardiotoxicity in primary neonatal rat cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes. Int J Mol Sci 17:E186
Zhao X, Kim SY, Park KY (2013) Bamboo salt has in vitro anticancer activity in HCT-116 cells and exerts anti-metastatic effects in vivo. J Med Food 16:9–19
Zheng LL, Cao YW, Liu S, Peng ZY, Zhang SD (2014) Neferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expression. Exp Ther Med 8:1545–1550
Zhou XL, Wang M (2015) Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis. Genet Mol Res 14:17059–17067
Zhu JJ, Shan JJ, Sun LB, Qiu WS (2015) Study of the radiotherapy sensitization effects and mechanism of capecitabine (Xeloda) against non-small-cell lung cancer cell line A549. Genet Mol Res 14(4):16386–16391
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dingyi Yang and Xiaochuan Zou have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yang, D., Zou, X., Yi, R. et al. Neferine increase in vitro anticancer effect of dehydroepiandrosterone on MCF-7 human breast cancer cells. Appl Biol Chem 59, 585–596 (2016). https://doi.org/10.1007/s13765-016-0199-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13765-016-0199-y